The FDA moved 12 peptides off its restricted list and reviews 7 in July 2026. See what it could mean for compounding, your GLP-1, and peptide safety.
B12, B6, niacinamide, glycine, benzyl alcohol: see what each GLP-1 additive does, the allergy risks, and how to search providers by additive.
Staying on a GLP-1 this summer? See how to avoid dehydration, store your pen below 86°F, travel safely, and what's true about sun sensitivity.
Insurers and employers are cutting GLP-1 coverage mid-year. See why, how to tell if your plan changed, cash-pay options from $299, and how to appeal.
CagriSema is under FDA review with a decision expected in 2026. See what the trials showed and how it compares to Wegovy and Zepbound.
What the research shows about GLP-1 medications for PCOS, including weight, testosterone, periods, and why it is still an off-label use.
A real patient shares her TrimRX experience, from flat $279 tirzepatide pricing to slow support, a warm late delivery, and a mismatched vial label.
The Medicare GLP-1 Bridge starts July 1, 2026. See who qualifies, which drugs cost $50, and how the prior authorization works step by step.
How GLP-1 medications affect weight, muscle, and bone in menopause, plus steps midlife women can take to protect lean mass and bone health.
AstraZeneca's elecoglipron, an experimental once-daily GLP-1 pill, is heading to Phase 3. See what the early results show and what is still unproven.
A pharmacy is suing Lilly and Novo over compounded GLP-1 access. See what the lawsuit claims, what the companies say, and what it means for you.
Two GLP-1 pills are now FDA approved, with more coming. See how oral options could change access, what they cost, and how they compare to shots.
